Invesaro

Stocks Health care LQDA

NASDAQ · Health care

Liquidia Corp (LQDA)

Liquidia Corp brought in $450.9M of revenue over the twelve months to June 30, 2026, up 2,233.6% from a year earlier. Net income was $138.6M, a net margin of 30.7%. In fiscal 2025 capital spending exceeded operating cash flow by $40M. At June 30, 2026 it held $284.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Free, no password. An email when LQDA files with the SEC.

Price
$47.87
+7.82% on the day · November 9, 2026
52-week range $22.31 to $93.61
Market cap
$4.3B
Revenue (last 12 months)
$450.9M
+2,233.6% year on year
Net margin
30.7%

Key facts about Liquidia Corp

Net worth
Liquidia Corp has a market value (market cap) of $4.3B at the latest share price, and shareholders' equity of $195.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $158.3M (+1,031.2% year on year), with a net loss of $68.9M. Over the 12 months to June 30, 2026: revenue $450.9M, net income $138.6M.
Cash flow
In fiscal 2025 operations used $35.7M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 12, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Liquidia Corp's next report was expected around November 2, 2026 and is not on file with the SEC yet.

What Liquidia Corp does

Liquidia Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LQDA.

Revenue and profit by year

Revenue
FY20: $8.1M $8.1M FY20FY20: $739.6K $739.6K FY20FY21: $12.9M $12.9M FY21FY22: $15.9M $15.9M FY22FY23: $17.5M $17.5M FY23FY24: $14M $14M FY24FY25: $158.3M $158.3M FY25
Net income
FY20: -$47.6M -$47.6M FY20FY20: -$59.8M -$59.8M FY20FY21: -$34.6M -$34.6M FY21FY22: -$41M -$41M FY22FY23: -$78.5M -$78.5M FY23FY24: -$128.3M -$128.3M FY24FY25: -$68.9M -$68.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$158.3M-$51.4M-$68.9M-$0.80-$40M
2024$14M-$121.3M-$128.3M-$1.63-$98.4M
2023$17.5M-$73.4M-$78.5M-$1.21-$42.9M
2022$15.9M-$38.8M-$41M-$0.67-$29.2M
2021$12.9M-$33.8M-$34.6M-$0.70-$34.1M
2020$739.6K-$59.1M-$59.8M-$1.76-$54.9M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

A report was expected around November 2, 2026 and is not on file yet.

Estimated from its filing rhythm: 52 weeks after its report of November 3, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where LQDA ranks in Health care

Revenue$158.3M
#292 of 751 in Health care · Top 39%
Revenue growth+1,031.2%
#10 of 532 in Health care · Top 2%
Net margin-43.5%
#392 of 544 in Health care · Bottom 28%
Free cash flow margin-25.3%
#337 of 490 in Health care · Bottom 31%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Liquidia Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 14, 2026
  2. September 30, 2026
  3. September 3, 2026
  4. August 14, 2026
  5. August 12, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 1,843% to $171.7M versus the same quarter last year; diluted EPS $0.74 versus -$0.49.
  6. August 12, 2026
  7. August 4, 2026
  8. July 8, 2026
  9. June 17, 2026
  10. June 8, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 28, 2026. Insider transactions on SEC

Insider trades

What the people running Liquidia Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $25.8M worth of shares in the last 90 days and bought none on the open market. 47% of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$25.8M
last 90 days
Net sold
566,853
$25.8M
DateInsiderWhatSharesPriceValueFiling
October 26, 2026 Adair JasonChief Business Officer Soldpre-planned (10b5-1) 688 $43.19 $29.7K Form 4
October 26, 2026 Boyle DanaChief Accounting Officer Soldpre-planned (10b5-1) 1,581 $43.19 $68.3K Form 4
October 12, 2026 Adair JasonChief Business Officer Soldpre-planned (10b5-1) 7,301 $28.48 $207.9K Form 4
October 12, 2026 Boyle DanaChief Accounting Officer Soldpre-planned (10b5-1) 5,892 $28.48 $167.8K Form 4
October 12, 2026 Jeffs RogerChief Executive Officer, Director Soldpre-planned (10b5-1) 32,744 $28.48 $932.5K Form 4
October 12, 2026 Kaseta MichaelCFO and COO Soldpre-planned (10b5-1) 18,938 $28.48 $539.4K Form 4
October 12, 2026 Khindri SanjeevChief Development Officer Soldpre-planned (10b5-1) 1,101 $28.48 $31.4K Form 4
October 12, 2026 Krepp SarahChief Human Resource Officer Soldpre-planned (10b5-1) 5,245 $28.48 $149.4K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns LQDA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Dapice Joshua J.13G, passive with 30 related filers 9.9% 8,656,038 February 9, 2026
David Johnson13D, may seek influence with 1 related filers 9.8% - September 12, 2024
Farallon Capital Management, L.L.C.13G, passive with 28 related filers 9.4% 8,365,038 August 4, 2026
Paul B Manning13G, passive with 2 related filers 6.5% 4,946,771 August 14, 2026

Latest filings below 5%: Legend Aggregator, LP 2.2% (February 12, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 336 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.10,788,586$860.2M+5,299,442
Farallon Capital Management, L.L.C.8,365,038$666.9M-291,000
Caligan Partners LP8,118,892$647.3M0
Findell Capital Management LLC3,502,112$279.2M0
Vanguard Capital Management LLC3,139,183$250.3M+212,238
State Street Corp3,030,395$241.6M+1,148,796
Opaleye Management Inc.2,447,500$195.1M-97,500
Geode Capital Management, LLC2,121,290$169.2M+192,321
Bank of America Corp1,991,566$158.8M-296,226
Vanguard Portfolio Management LLC1,532,151$122.2M+899,526
Caprock Group, LLC1,409,759$112.4M+42,524
Mpm Bioimpact LLC1,386,174$110.5M-18,984
D. E. Shaw & Co., Inc.1,267,706$101.1M+394,641
Fuller & Thaler Asset Management, Inc.1,209,604$96.4Mnew
Goldman Sachs Group Inc958,892$76.5M+146,902
Federated Hermes, Inc.816,187$65.1M+377,420
Northern Trust Corp709,063$56.5M+129,188
Charles Schwab Investment Management Inc674,033$53.7M+116,833
Morgan Stanley658,441$52.5M+313,770
Boothbay Fund Management, LLC622,716$49.6M-2,332

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

18 insiders reported holding 21,831,522 shares in total, about $1.05B at the last price.

HolderSharesAs of
Caligan Partners LPDirector, 10% owner 16,272,60216,272,602 held indirectly May 19, 2026
Jeffs RogerChief Executive Officer, Director 2,167,5151,041,667 held indirectly October 12, 2026
Manning Paul BDirector 1,273,800798,335 held indirectly June 16, 2026
Schundler RussellGeneral Counsel 602,841 October 12, 2026
Kaseta MichaelCFO and COO 340,148 October 12, 2026
Moomaw ScottChief Commercial Officer 181,487 October 12, 2026
Adair JasonChief Business Officer 177,269 October 26, 2026
Boyle DanaChief Accounting Officer 164,028 October 26, 2026
Saggar RajeevChief Medical Officer 126,368 October 12, 2026
Krepp SarahChief Human Resource Officer 115,241 October 12, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about LQDA

What does Liquidia Corp do?

Liquidia Corp is a company in the Health care sector, listed on NASDAQ as LQDA. Its shares trade on NASDAQ under the ticker LQDA.

What is Liquidia Corp's net worth?

Liquidia Corp has a market value (market cap) of $4.3B at the latest share price, and shareholders' equity of $195.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Liquidia Corp profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $138.6M on revenue of $450.9M, a net margin of 30.7%.

How much revenue does Liquidia Corp make?

Over the twelve months to June 30, 2026 Liquidia Corp reported revenue of $450.9M. That is 2,233.6% more than a year earlier.

When did Liquidia Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 28, 2026.

When is Liquidia Corp's next earnings report?

Liquidia Corp's next report was expected around November 2, 2026 and is not on file with the SEC yet.

Similar companies

Compare LQDA with

Compare LQDA with any company

Follow LQDA

Get an email when Liquidia Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when LQDA files with the SEC.

Where the numbers come from

Financial figures are the values Liquidia Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.